Australia's S&P/ASX 200 (Index: ^AXJO)(ASX: XJO) and ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) indices finished lower on Wednesday.
Here's a short recap of the Australian market:
- S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) lower 0.29% to 6,247.60
- ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) lower 0.21% to 6,341.70
- AUD/USD at US 74 cents
- Gold at US$1,225.65 an ounce
- Brent Oil at US$74.07 a barrel
The best-performing ASX 200 share today was Cimic Group Ltd (ASX: CIM), the contractor business finished up 4.7%.
At the other end of the performance table, pet business Greencross Limited (ASX: GXL) fell by 6.5%, wiping out the gains it has made over the past month.
The Kogan.Com Ltd (ASX: KGN) share price fell by a further 11% after the company's update yesterday wasn't as good as investors expected.
Medical Developments International Ltd (ASX: MVP) shares plunged 19.5% today after the US FDA delayed the Penthrox clinical program.
The Pinnacle Investment Management Group Ltd (ASX: PNI) share price returned to trade today after going into a trading halt for a capital raising and finished higher by 10.2%.
The share price of Nufarm Limited (ASX: NUF) dropped another 4.4% after its market update on Monday disappointed investors.
Annuity company Challenger Ltd (ASX: CGF) fell by 2.86% today.
Finally, Somnomed Limited (ASX: SOM) shares climbed 13.6% higher after it revealed revenue growth of 30% in FY18.
Here are some of today's top stories:
